Gainers
• IMV, Inc. IMV shares surged 99.01% to $4.04 during Wednesday's pre-market session. The most recent rating by B. Riley FBR, on Feb 28, is at Buy, with a price target of $7.
• Vaxart, Inc. VXRT shares increased by 49.22% to $2.88.
• Achieve Life Sciences, Inc. ACHV shares moved upwards by 44.18% to $0.39. The most recent rating by H.C. Wainwright, on Feb 25, is at Buy, with a price target of $2.
• BioNTech, Inc. BNTX shares moved upwards by 42.64% to $95. The most recent rating by JP Morgan, on Mar 18, is at Neutral, with a price target of $33.
• Neon Therapeutics, Inc. NTGN shares rose 20.99% to $3.17. The most recent rating by Morgan Stanley, on Jan 21, is at Equal-Weight, with a price target of $2.
• DBV Technologies, Inc. DBVT shares rose 20.60% to $2.81. The most recent rating by Stifel, on Mar 17, is at Hold, with a price target of $6.
• T2 Biosystems, Inc. TTOO stock moved upwards by 15.71% to $0.37.
• Heat Biologics, Inc. HTBX stock increased by 14.07% to $0.69. The most recent rating by Maxim Group, on Feb 6, is at Buy, with a price target of $1.
• Diffusion Pharmaceuticals, Inc. DFFN stock rose 12.28% to $0.32.
• OpGen, Inc. OPGN stock moved upwards by 3.76% to $3.31.
Losers
• Cronos Group, Inc. CRON stock fell 13.59% to $5.15 during Wednesday's pre-market session.
• Moleculin Biotech, Inc. MBRX stock plummeted 10.98% to $0.46.
• Sanofi, Inc. SNY stock fell 8.92% to $39.72. According to the most recent rating by Goldman Sachs, on Mar 11, the current rating is at Buy.
• Canopy Growth, Inc. CGC shares decreased by 8.48% to $9.50. The most recent rating by Stifel Nicolaus, on Feb 18, is at Buy, with a price target of $35.
• Royal Philips, Inc. PHG shares declined 8.32% to $31.18. The most recent rating by Bank of America, on Jan 13, is at Buy, with a price target of $51.
• Grifols, Inc. GRFS shares plummeted 7.53% to $16.33.
• Alcon, Inc. ALC shares plummeted 7.37% to $43.93. According to the most recent rating by UBS, on Mar 13, the current rating is at Buy.
• Rite Aid, Inc. RAD stock decreased by 7.32% to $15.70.
• Galapagos, Inc. GLPG shares declined 6.37% to $147.65. The most recent rating by RBC Capital, on Mar 18, is at Sector Perform, with a price target of $157.
• GNC Holdings, Inc. GNC shares decreased by 6.23% to $0.45. The most recent rating by Jefferies, on Mar 17, is at Underperform, with a price target of $0.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.